Background: The monocyte-to-lymphocyte ratio (MLR) has been advocated as a biomarker in tuberculosis. Our objective was to evaluate its clinical value and associations.
Methods: Blood counts, inflammatory markers and clinical parameters were measured in patients with and those screened for tuberculosis.